By Oliver Hirt and Paul Arnold ZURICH (Reuters) – Swiss insurer Baloise is under pressure to heed shareholder demands to shake up its portfolio and boost returns since activist investor Cevian Capital said it held over 9% of the company’s stock, becoming its biggest stakeholder. Over the past decade, returns on Baloise’s shares, including dividends, …
Investors press Baloise to shake up business after Cevian swoop Read More »
BRUSSELS (Reuters) – The European Union will lower proposed final tariffs on Tesla and slightly trim rates for other electric vehicles from China after taking into account submissions by the companies, a source familiar with the matter said on Tuesday. Tesla’s proposed tariff rate will drop to 7.8%, from 9%, the source said. For BYD, …
EU to trim proposed tariffs on Tesla, other EVs from China Read More »
By Arunima Kumar (Reuters) -Serica Energy’s new CEO said on Tuesday that its oil and gas producing assets remain cash generative, despite what he called “unjustifiably punitive” British taxes. Britain’s new Labour government said last month it would raise the Energy Profits Levy (EPL) imposed in 2022, by 3% to 38% from Nov. 1, bringing …
Serica CEO says assets cash generative despite planned UK tax hike Read More »
By Maria Martinez BERLIN (Reuters) – Around 20% of industrial value creation in Germany is under threat, according to a study published by the business association BDI on Tuesday. Germany is under more pressure as a business location than ever before in what should be a wake-up call for urgent reforms and investments, BDI said. …
Fifth of industrial value creation in Germany under threat, BDI says Read More »
(Reuters) – Shares in European hearing aid makers slipped in early trading on Tuesday after Apple rolled out hearing aid features. Apple said its AirPods Pro 2 could now be “transformed” into a personalized hearing aid via an upcoming software update that would boost specific sounds in real time, including parts of speech or elements …
(Reuters) -London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company’s lung cancer trials showed that its experimental precision drug did not significantly improve overall survival results for patients. The stock fell as much as 5.6% to 119.98 pounds in morning trade, with shares, which have gained nearly 18% this year, …
AstraZeneca stock drops after lung cancer drug trial setback Read More »
By Allison Lampert (Reuters) -Boeing has told suppliers it is delaying a key production milestone for its 737 MAX by six months, three industry sources said, in a sign the planemaker is struggling to boost production of its best-selling jet. Boeing’s latest 737 supplier master schedule communicated to the industry calls for MAX output to …
Exclusive-Boeing delays suppliers’ 737 MAX output goal by 6 months, sources say Read More »
By Stefano Rebaudo (Reuters) – Sterling edged up versus the dollar and the euro on Tuesday after UK labour data supported the view that the British economy was on a solid footing. Pay growth cooled in the three months to July to a more than two-year low, and employment shot higher, according to data on …
Sterling edges up versus dollar and euro after UK data Read More »
By Pranav Kashyap (Reuters) – European shares climbed on Tuesday, boosted by the real-estate sector, while investors also awaited the widely expected rate cut by the European Central Bank later in the week. The pan-European STOXX 600 index rose 0.3% after gaining nearly 1% on Monday. Rate-sensitive real estate sector advanced 1% ahead of the …
By DhanushVignesh Babu (Reuters) -British semiconductor wafer maker IQE said on Tuesday it expects annual profit to be at the lower end of analysts’ estimates as some of its markets were slower to recover from a supply glut, sending its shares 13% lower. IQE, whose ‘epi-wafers’ are used in the iPhone’s facial recognition sensors, expects …
Apple supplier IQE expects annual profit at lower end of market view Read More »
